Olaplex Reports $5.3 Million Net Loss in Q1 2026 Despite Revenue Growth

Olaplex Holdings, Inc. reported a net loss of $5.3 million for the first quarter of 2026, a significant decline from a net income of $465,000 in the same period of 2025. The company's revenue for the quarter reached $99.4 million, reflecting a 2.5% increase from $97.0 million year-over-year. The growth in sales was driven primarily by a 12.3% increase in the professional channel and a 13.8% rise in direct-to-consumer sales, although the specialty retail segment saw a decline of 13.3%. The gross profit margin improved to 72.1%, up from 69.5% in the prior year, attributed to a decrease in the cost of sales.

Operating expenses surged to $76.8 million, a 30.4% increase compared to $58.9 million in the previous year. This rise was largely due to higher selling, general, and administrative expenses, which included $7.4 million in merger-related costs and increased marketing expenditures. Interest expenses also decreased significantly to $7.1 million from $13.7 million, reflecting a reduction in outstanding debt following a $300 million repayment on the 2022 Term Loan Facility in May 2025.

Olaplex's balance sheet as of March 31, 2026, showed total assets of $1.46 billion, down from $1.50 billion at the end of 2025. Current assets decreased to $446.3 million, primarily due to a reduction in prepaid expenses and other current assets. The company’s cash and cash equivalents increased slightly to $326.2 million, while total liabilities decreased to $582.2 million, down from $618.1 million. The company maintained a strong liquidity position with $476.2 million available, including cash and borrowing capacity under its credit facilities.

Strategically, Olaplex is in the process of merging with Henkel US Operations Corporation, with the merger agreement signed on March 26, 2026. Under the terms of the agreement, shareholders will receive $2.06 per share in cash. The merger is expected to close in the second half of 2026, subject to customary closing conditions. The company has also waived certain rights under its Tax Receivable Agreement in connection with the merger, which could have significant financial implications depending on the agreement's future status.

Looking ahead, Olaplex aims to enhance its product offerings and marketing strategies while expanding its market presence. The company is focused on energizing its core products, fueling science-based innovation, and optimizing its go-to-market model to drive growth. However, it remains cautious of macroeconomic factors, including inflation and competitive pressures, that could impact consumer spending and demand for its products.